Study of the relations between small cell lung cancer and the APUd system based on the analysis of clinical, biological and molecular-genetic properties
Słodkowska, J.
Postepy Higieny i Medycyny Doswiadczalnej 43(5-6): 499-510
1989
ISSN/ISBN: 0032-5449 PMID: 2577339 Document Number: 339155
The paper presents the latest opinions dealing with biological features (the hormone production) and histogenesis of the small cell lung cancer (SCLC). The authors try to explain the problem of the rapid progression of SCLC as well as the rapid insensitivity to radiation and chemotherapy following initial responsiveness of SCLC.
Document emailed within 1 workday
Related Documents
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12Schreiber, G.; Pitterle, D.; Kim, Y.C.; Bepler, G. 1999: Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung Anticancer Research 19(2a): 1109-1115
Nagai, M.; Oguma, H.; Arai, F.; Watanabe, E.; Nakazawa, M. 2014: Analysis of initial treatment only by linac-based stereotactic radiosurgery for a metastatic brain tumor from non-small cell lung cancer No Shinkei Geka. Neurological Surgery 42(4): 327-334
Horinouchi, H.; Iwamaru, A.; Abiko, T.; Kuwabara, K.; Kouno, M.; Tajima, M.; Sawafuji, M.; Watanabe, M.; Kawamura, M.; Kobayashi, K. 1998: Clinical analysis in patients undergoing extended resection of pT3 non-small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 51(11): 926-929
Liu, R.; Song, Q.; Zhang, Z.; Yang, Z.; Liu, Y.; Zhang, X. 2015: TNF-β genetic variant contributes to the risk of non-small cell lung cancer Zhonghua Yu Fang Yi Xue Za Zhi 49(1): 41-44
Erlich, R.; Levitt, M.L. 1995: Update in the treatment and molecular biology of non-small cell lung cancer Comprehensive Therapy 21(8): 445-457
Niklinska, W.; Chyczewski, L.; Niklinski, J. 2001: New molecular approaches to lung cancer: biological and clinical implications of P53, P16 and K-RAS studies Folia Histochemica et Cytobiologica 39(2): 99-103
Shi, Y.; Sun, Y. 2015: Molecular targeted therapy of non-small cell lung cancer in China: the first 10 years Zhonghua Yi Xue Za Zhi 95(8): 564-569
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
Terasaki, T.; Kameya, T.; Nakajima, T.; Tsumuraya, M.; Shimosato, Y.; Kato, K.; Ichinose, H.; Nagatsu, T.; Hasegawa, T. 1984: Interconversion of biological characteristics of small cell lung cancer depending on culture conditions Gan 75(12): 1089-1099
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
Vogt, H.G.; Kolotas, C.; Martin, T.; Schneider, L.V.; Goes-Schmieder, R.; Mitrou, P.S.; Diergarten, K.; Kober, B.; Zamboglou, N. 1996: Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase i study Seminars in Oncology 23(6 Suppl 16: 120-123
Hu, L.-h.; Wu, Y.; Lu, G.-h.; Chen, Q.-y.; Wang, Y.-h.; Zhou, J.-y. 2010: Correlation of the expression of IIi β-tubulin and MDR1 protein with biological features of non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 32(10): 762-766
Iizasa, T.; Fujisawa, T. 2001: Surgery for non-small cell lung cancer based on the T factor Nihon Geka Gakkai Zasshi 102(7): 507-510
Socha, J.; Kołodziejczyk, M.; Kępka, L. 2013: Outcome after PET-CT based radiotherapy for non-small cell lung cancer Pneumonologia i Alergologia Polska 81(1): 30-39
Van Zandwijk, N.; Dalesio, O. 1994: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer Seminars in Oncology 21(3 Suppl 6: 66-71
Kumar, A.; Ramanathan, K. 2015: Analyzing resistance pattern of non-small cell lung cancer to crizotinib using molecular dynamic approaches Indian Journal of Biochemistry and Biophysics 52(1): 23-28
Wang, L.; Liao, M-Lin.; Li, L-Yun.; Wan, H-Ying.; Xu, N.; Liu, J-Wei.; Liang, H-Jie. 2004: Clinical benefit of gemcitabine plus cisplatin 3-week regimen for patients with advanced non-small cell lung cancer: a prospective observational study Chinese Medical Journal 117(11): 1607-1610
Rocha Lima, C.M.S.; Joppert, M.G. 2002: Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer Oncology 16(9 Suppl 9: 25-31
Acharyya, S.; Sau, S.; Dasgupta, P.; Chakraborty, A.; Gangopadhyay, S. 2012: Skin rash as a surrogate marker of clinical response of targeted therapy using gefitinib in advanced or metastatic non-small-cell lung cancer--a retrospective study Journal of the Indian Medical Association 110(7): 474-6 493